← FDA Drug Approvals (Drugs@FDA)

MICAFUNGIN SODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BIOCON PHARMA · Approved 2024-05-29

Drug application

FDA Application #

ANDA216438

Application type

Abbreviated New Drug Application (Generic)

Brand name

MICAFUNGIN SODIUM

Generic name

MICAFUNGIN

Active ingredients

MICAFUNGIN SODIUM

Dosage form

INJECTABLE

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

BIOCON PHARMA

Manufacturer

Biocon Pharma Inc.

First approval

2024-05-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown